Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Serotonin-release assay-negative heparin-induced thrombocytopenia.

Warkentin TE, Nazy I, Sheppard JI, Smith JW, Kelton JG, Arnold DM.

Am J Hematol. 2019 Oct 17. doi: 10.1002/ajh.25660. [Epub ahead of print]

PMID:
31621093
2.

Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay.

Warkentin TE, Sheppard JI, Smith JW, Arnold DM, Nazy I.

Int J Lab Hematol. 2019 Aug;41(4):493-502. doi: 10.1111/ijlh.13031. Epub 2019 May 3.

3.

The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test.

Vrbensky JR, Moore JE, Arnold DM, Smith JW, Kelton JG, Nazy I.

J Thromb Haemost. 2019 May;17(5):787-794. doi: 10.1111/jth.14419. Epub 2019 Mar 20.

PMID:
30801909
4.

A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia.

Ivetic N, Arnold DM, Smith JW, Huynh A, Kelton JG, Nazy I.

Platelets. 2019;30(8):1017-1021. doi: 10.1080/09537104.2018.1562169. Epub 2019 Jan 29.

PMID:
30693813
5.

An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia.

Eekels JJM, Althaus K, Bakchoul T, Kroll H, Kiefel V, Nazy I, Lee LS, Sachs U, Warkentin TE, Greinacher A.

J Thromb Haemost. 2019 Mar;17(3):525-531. doi: 10.1111/jth.14383. Epub 2019 Feb 20.

PMID:
30640980
6.

Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.

Huynh A, Arnold DM, Kelton JG, Smith JW, Horsewood P, Clare R, Guarné A, Nazy I.

J Thromb Haemost. 2019 Feb;17(2):389-399. doi: 10.1111/jth.14369. Erratum in: J Thromb Haemost. 2019 Sep;17(9):1578.

PMID:
30582672
7.

High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT.

Warkentin TE, Sheppard JI, Linkins LA, Arnold DM, Nazy I.

Blood. 2018 Sep 20;132(12):1345-1349. doi: 10.1182/blood-2018-04-847483. Epub 2018 Jul 31. No abstract available.

8.

Megakaryocyte apoptosis in immune thrombocytopenia.

Vrbensky JR, Nazy I, Toltl LJ, Ross C, Ivetic N, Smith JW, Kelton JG, Arnold DM.

Platelets. 2018 Nov;29(7):729-732. doi: 10.1080/09537104.2018.1475637. Epub 2018 May 22.

PMID:
29787328
9.

Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.

Nazy I, Clare R, Staibano P, Warkentin TE, Larché M, Moore JC, Smith JW, Whitlock RP, Kelton JG, Arnold DM.

J Thromb Haemost. 2018 Jul;16(7):1402-1412. doi: 10.1111/jth.14132. Epub 2018 Jun 5.

PMID:
29723924
10.

Statins for high cholesterol … and for low platelets?

Nazy I, Cuker A.

Blood. 2018 Mar 15;131(11):1159-1161. doi: 10.1182/blood-2018-01-824888. No abstract available.

PMID:
29545404
11.

Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia.

Nazy I, Kelton JG, Moore JC, Clare R, Horsewood P, Smith JW, Ivetic N, D'Souza V, Li N, Arnold DM.

Br J Haematol. 2018 Apr;181(2):234-241. doi: 10.1111/bjh.15165. Epub 2018 Mar 13.

PMID:
29532903
12.

Bacterial neuraminidase-mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure.

Qadri SM, Donkor DA, Nazy I, Branch DR, Sheffield WP.

Eur J Haematol. 2018 May;100(5):502-510. doi: 10.1111/ejh.13047. Epub 2018 Mar 30.

PMID:
29453885
13.

Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.

Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I.

Chest. 2018 Jun;153(6):1396-1404. doi: 10.1016/j.chest.2018.01.001. Epub 2018 Jan 8.

PMID:
29325985
14.

Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry.

Arnold DM, Nazy I, Clare R, Jaffer AM, Aubie B, Li N, Kelton JG.

Blood Adv. 2017 Nov 28;1(25):2414-2420. doi: 10.1182/bloodadvances.2017010942. eCollection 2017 Nov 28.

15.

Development of a high-yield expression and purification system for platelet factor 4.

Huynh A, Arnold DM, Moore JC, Smith JW, Kelton JG, Nazy I.

Platelets. 2018 May;29(3):249-256. doi: 10.1080/09537104.2017.1378808. Epub 2017 Nov 27.

PMID:
29172900
16.

The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia.

Arnold DM, Vrbensky JR, Karim N, Smith JW, Liu Y, Ivetic N, Kelton JG, Nazy I.

Br J Haematol. 2017 Jul;178(2):302-307. doi: 10.1111/bjh.14664. Epub 2017 Apr 25.

PMID:
28444742
17.

Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL® HIT-Ab(PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia.

Warkentin TE, Sheppard JI, Linkins LA, Arnold DM, Nazy I.

Thromb Res. 2017 May;153:108-117. doi: 10.1016/j.thromres.2017.03.010. Epub 2017 Mar 11.

18.

The unique immunological features of heparin-induced thrombocytopenia.

Staibano P, Arnold DM, Bowdish DM, Nazy I.

Br J Haematol. 2017 Apr;177(2):198-207. doi: 10.1111/bjh.14603. Epub 2017 Apr 3. Review.

PMID:
28369702
19.

Thrombotic microangiopathies: a general approach to diagnosis and management.

Arnold DM, Patriquin CJ, Nazy I.

CMAJ. 2017 Jan 30;189(4):E153-E159. doi: 10.1503/cmaj.160142. Epub 2016 Oct 17. Review. No abstract available.

Supplemental Content

Support Center